CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD..The latest application filed is for "crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof".

Company Profile

50.31.45

CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. - Suzhou CN
CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. - Suzhou , Jiangsu CN
Crystal Pharmaceutical (Suzhou) Co., Ltd. - Jiangsu N/A CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Form Of Valbenazine Ditosylate, Processes For Preparation Thereof And Use Thereof App 20220267326 - CHEN; Minhua ; et al.	2022-08-25
Crystal Form Of Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitor App 20220251044 - CHEN; Minhua ; et al.	2022-08-11
Crystal Form Of Upadacitinib, Preparation Method Therefor, And Use Thereof App 20220204519 - CHEN; Minhua ; et al.	2022-06-30
Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof Grant 11,339,158 - Chen , et al. May 24, 2	2022-05-24
Crystal Form Of Upadacitinib And Preparation Method And Use Thereof App 20220002306 - LIU; Jiajia ; et al.	2022-01-06
Upadacitinib Crystal Form And Preparation Method Therefor And Use Thereof App 20210380596 - CHEN; Minhua ; et al.	2021-12-09
Crystalline Forms Of Gft-505, Processes For Preparation And Use Thereof App 20210363101 - Chen; Minhua ; et al.	2021-11-25
Crystal Form Of Tafamidis And Preparation Method Therefor And Use Thereof App 20210363116 - CHEN; Minhua ; et al.	2021-11-25
Cabozantinib Malate Crystal Form, Preparation Method And Use Thereof App 20210332014 - Chen; Minhua ; et al.	2021-10-28
Crystalline form of EB-1020, processes for preparation and use thereof Grant 11,149,004 - Chen , et al. October 19, 2	2021-10-19
Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof Grant 11,136,347 - Chen , et al. October 5, 2	2021-10-05
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20210300893 - Chen; Minhua ; et al.	2021-09-30
Crystal form of Baricitinib and preparation method thereof Grant 11,124,517 - Chen , et al. September 21, 2	2021-09-21
Crystal form of acalabrutinib and preparation method and use thereof Grant 11,091,494 - Chen , et al. August 17, 2	2021-08-17
Crystalline forms of ARN-509, preparation method and use thereof Grant 11,066,384 - Chen , et al. July 20, 2	2021-07-20
Crystalline Form Of Eb-1020, Processes For Preparation And Use Thereof App 20210179558 - Chen; Minhua ; et al.	2021-06-17
Crystalline Forms Of Selective Progesterone Receptor Modulator, Processes For Preparation Thereof App 20210171568 - Chen; Minhua ; et al.	2021-06-10
Crystalline Forms Of A Fatty Acid Bile Acid Conjugate, Preparation Method Thereof And Use Thereof App 20210147471 - Chen; Minhua ; et al.	2021-05-20
Crystal Form Of Baricitinib And Preparation Method Thereof App 20210147423 - CHEN; Minhua ; et al.	2021-05-20
New Crystal Form Of Acalbrutinib, Preparation Method Therefor And Use Thereof App 20210087195 - Chen; Minhua ; et al.	2021-03-25
A Crystalline Form Of Valbenazine Ditosylate, Processes For Preparation Thereof And Use Thereof App 20210078993 - Chen; Minhua ; et al.	2021-03-18
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20210017148 - Chen; Minhua ; et al.	2021-01-21
Novel Crystal Form Of Acalabrutinib And Preparation Method And Use Thereof App 20200347069 - Chen; Minhua ; et al.	2020-11-05
Crystalline Form Of Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20200339524 - Chen; Minhua ; et al.	2020-10-29
Crystal forms of an androgen receptor antagonist, preparation method and use thereof Grant 10,815,221 - Chen , et al. October 27, 2	2020-10-27
Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereof Grant 10,815,232 - Chen , et al. October 27, 2	2020-10-27
Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof Grant 10,759,779 - Chen , et al. Sep	2020-09-01
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20200270226 - Chen; Minhua ; et al.	2020-08-27
Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof Grant 10,752,595 - Chen , et al. A	2020-08-25
Crystal Form Of Androgen Receptor Antagonist Medication, Preparation Method Therefor, And Use App 20200239450 - CHEN; Minhua ; et al.	2020-07-30
Crystalline Forms Of Gsk1278863, Preparation Method And Pharmaceutical Use Thereof App 20200216399 - Chen; Minhua ; et al.	2020-07-09
Crystal Forms Of Ozanimod And Preparation Method Therefor App 20200216404 - CHEN; Minhua ; et al.	2020-07-09
Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof Grant 10,703,724 - Chen , et al.	2020-07-07
Crystalline Form Of Orexin Receptor Antagonist, Processes For Preparation Thereof And Use Thereof App 20200190060 - Chen; Minhua ; et al.	2020-06-18
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20200157065 - Chen; Minhua ; et al.	2020-05-21
Crystalline forms of JAK1-selective inhibitor, processes for preparation and use thereof Grant 10,633,376 - Chen , et al.	2020-04-28
Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof Grant 10,626,135 - Chen , et al.	2020-04-21
Galunisertib crystalline form, preparation method thereof and use thereof Grant 10,604,528 - Chen , et al.	2020-03-31
Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof Grant 10,604,521 - Chen , et al.	2020-03-31
Novel Crystalline Forms Of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] Amino} Acetic Acid And Processes For Preparation T App 20200095203 - Chen; Minhua ; et al.	2020-03-26
Galunisertib crystalline form, preparation method thereof and use thereof Grant 10577372 -	2020-03-03
Crystalline Forms Of Viral-protein Inhibitor Drug Vx-787, Processes For Preparation Thereof And Use Thereof App 20190352303 - Chen; Minhua ; et al.	2019-11-21
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20190337908 - CHEN; Minhua ; et al.	2019-11-07
Crystalline Forms Of A Bromodomain And Extraterminal Protein Inhibitor Drug, Processes For Preparation Thereof, And Use Thereof App 20190330161 - Chen; Minhua ; et al.	2019-10-31
Crystal forms of NBI-98854, preparation method and use thereof Grant 10,442,800 - Chen , et al. Oc	2019-10-15
Crystalline Forms Of Plx3397 Hydrochloride, Processes For Preparation And Use Thereof App 20190256510 - Chen; Minhua ; et al.	2019-08-22
Crystal Form Of Ozanimod Hydrochloride, And Preparation Method Therefor App 20190248755 - CHEN; Minhua ; et al.	2019-08-15
Galunisertib Crystalline Form, Preparation Method Thereof And Use Thereof App 20190241572 - Chen; Minhua ; et al.	2019-08-08
Crystal Forms Of Nbi-98854, Preparation Method And Use Thereof App 20190218209 - Chen; Minhua ; et al.	2019-07-18
Crystalline Forms Of Jak1-selective Inhibitor, Processes For Preparation And Use Thereof App 20190177314 - Chen; Minhua ; et al.	2019-06-13
New Crystal Form Of Sodium-glucose Co-transporter Inhibitor Processes For Preparation And Use Thereof App 20190169219 - CHEN; Minhua ; et al.	2019-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.